Lazard Asset Management
TVTX icon

Lazard Asset Management’s Travere Therapeutics TVTX Stock Holding History

Lazard Asset Management’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,984
Closed -$381K – 2086
2025
Q4 		$381K Buy
+9,984
New +$325K ﹤0.01% 1460
2025
Q3 		– Sell
-5,461
Closed -$80K – 2324
2025
Q2 		$80K Sell
5,461
-4,457
-45% -$73.9K ﹤0.01% 1913
2025
Q1 		$177K Buy
9,918
+4,201
+73% +$85.3K ﹤0.01% 1656
2024
Q4 		$99K Buy
+5,717
New +$101K ﹤0.01% 1800
2023
Q4 		– Sell
-11,862
Closed -$106K – 2474
2023
Q3 		$106K Sell
11,862
-45,038
-79% -$636K ﹤0.01% 1612
2023
Q2 		$873K Sell
56,900
-44,515
-44% -$810K ﹤0.01% 1017
2023
Q1 		$2.28M Sell
101,415
-24,174
-19% -$514K ﹤0.01% 894
2022
Q4 		$2.64M Buy
+125,589
New +$2.66M ﹤0.01% 857
2022
Q3 		– Sell
-703
Closed -$17K – 2561
2022
Q2 		$17K Sell
703
-51
-7% -$1.28K ﹤0.01% 2153
2022
Q1 		$19K Sell
754
-4,299
-85% -$114K ﹤0.01% 2081
2021
Q4 		$156K Buy
5,053
+578
+13% +$16.3K ﹤0.01% 1328
2021
Q3 		$108K Buy
+4,475
New +$82.2K ﹤0.01% 1401
2021
Q1 		– Sell
-3,616
Closed -$98K – 2028
2020
Q4 		$98K Hold
3,616
– – ﹤0.01% 1189
2020
Q3 		$66K Sell
3,616
-1,970
-35% -$38.3K ﹤0.01% 1106
2020
Q2 		$114K Buy
5,586
+1,267
+29% +$20.2K ﹤0.01% 992
2020
Q1 		$63K Buy
+4,319
New +$65K ﹤0.01% 1111
2019
Q4 		– Sell
-875
Closed -$10K – 1669
2019
Q3 		$10K Buy
+875
New +$14.5K ﹤0.01% 1309

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Lazard Asset Management's TVTX Position: Q1 2026 in Review

Lazard Asset Management sold out of Travere Therapeutics (TVTX) in Q1 2026, closing a stake of 9,984 shares — an estimated $381K sold.

Lazard Asset Management first reported a position in TVTX in Q3 2019 and held it in 17 quarters. The position peaked at $2.64M in Q4 2022. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Lazard Asset Management reported no remaining Travere Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Lazard Asset Management sold 9,984 Travere Therapeutics shares in Q1 2026, an estimated $381K.
  • Lazard Asset Management first reported a position in Travere Therapeutics in Q3 2019 and held it in 17 quarters.
  • Lazard Asset Management's Travere Therapeutics position peaked at $2.64M in Q4 2022.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.